If the data is great (and I think it will be) this will go ballistic. Countries would be vying to get their hands on some. BP will be vying for distribution rights. And FDA will be under enormous pressure to approve or at least give us tons of money to hurry the phase 3 trials along, if so requested. In the meantime, we can sell to other countries.